Bio Spec Overview
Ignite Creation Date:
2025-12-25 @ 12:53 AM
Last Modification Date:
2025-12-25 @ 12:53 AM
Retention:
SAMPLES_WITH_DNA
Description:
1. Lung explants from end-stage CF and control patients, which were obtained for a reason independent from the study.
2. Sputum, nasal (fluid) and serum samples from CF patients and controls patients (COPD patients and healthy subjects) will be collected for S-IgA and microbiological assays. Spontaneous sputum will be collected, while nasal fluid will be sampled through nasal lavage.
3. Endobronchial biopsies and broncho-alveolar lavage will be sampled in some CF patients who must have a general anaesthesia for a reason independent from the study. If possible, nasal and rectal biopsies will also be performed. Control subjects will be patients without evidence of lung disease and who are undergoing narcosis for an independent reason.
Section:
1. Lung explants from end-stage CF and control patients, which were obtained for a reason independent from the study.
2. Sputum, nasal (fluid) and serum samples from CF patients and controls patients (COPD patients and healthy subjects) will be collected for S-IgA and microbiological assays. Spontaneous sputum will be collected, while nasal fluid will be sampled through nasal lavage.
3. Endobronchial biopsies and broncho-alveolar lavage will be sampled in some CF patients who must have a general anaesthesia for a reason independent from the study. If possible, nasal and rectal biopsies will also be performed. Control subjects will be patients without evidence of lung disease and who are undergoing narcosis for an independent reason.